Nonvirally modified autologous primary hepatocytes correct diabetes and prevent target organ injury in a large preclinical model.
<h4>Background</h4>Current gene- and cell-based therapies have significant limitations which impede widespread clinical application. Taking diabetes mellitus as a paradigm, we have sought to overcome these limitations by ex vivo electrotransfer of a nonviral insulin expression vector int...
Saved in:
Main Authors: | Nelson K F Chen, Jen San Wong, Irene H C Kee, Siang Hui Lai, Choon Hua Thng, Wai Har Ng, Robert T H Ng, Soo Yong Tan, Shu Yen Lee, Mark E H Tan, Jaichandran Sivalingam, Pierce K H Chow, Oi Lian Kon |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2008
|
Subjects: | |
Online Access: | https://doaj.org/article/d6d641e5934441eda05c41c85f05a2af |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted nonviral gene therapy in prostate cancer
by: Altwaijry N, et al.
Published: (2018) -
Chromosomal breaks at FRA18C: association with reduced DOK6 expression, altered oncogenic signaling and increased gastric cancer survival
by: Siew Hong Leong, et al.
Published: (2017) -
Research progress on siRNA delivery with nonviral carriers
by: Gao Y, et al.
Published: (2011) -
Therapeutic efficacy of lenvatinib in nonviral unresectable hepatocellular carcinoma
by: Tetsu Tomonari, et al.
Published: (2021) -
Polyethylenimine600-β-cyclodextrin: a promising nanopolymer for nonviral gene delivery of primary mesenchymal stem cells
by: Tong H, et al.
Published: (2013)